GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $20.00 $20.00 Wednesday, 15th Apr 2020 ARQL stock ended at $20.00. During the day the stock fluctuated 0% from a day low at $20.00 to a day high of $20.00.
90 days $20.00 $20.00
52 weeks $5.76 $20.45

Historical ArQule prices

Date Open High Low Close Volume
2019-08-05 $9.86 $9.93 $9.41 $9.47 2 075 312
2019-08-02 $10.22 $10.29 $9.88 $9.94 1 626 949
2019-08-01 $10.03 $10.61 $9.91 $10.30 1 489 170
2019-07-31 $10.37 $10.50 $10.06 $10.09 1 128 949
2019-07-30 $10.22 $10.39 $10.06 $10.37 811 886
2019-07-29 $10.39 $10.59 $10.22 $10.31 995 747
2019-07-26 $10.44 $10.49 $10.14 $10.40 1 609 880
2019-07-25 $10.51 $10.60 $10.34 $10.39 1 501 432
2019-07-24 $10.52 $10.60 $10.29 $10.50 1 154 940
2019-07-23 $11.03 $11.07 $10.49 $10.53 1 140 439
2019-07-22 $10.60 $10.95 $10.52 $10.91 1 103 582
2019-07-19 $10.61 $10.76 $10.44 $10.57 1 284 168
2019-07-18 $10.29 $10.82 $10.25 $10.60 1 724 361
2019-07-17 $10.62 $10.62 $10.27 $10.33 1 172 956
2019-07-16 $10.60 $10.73 $10.41 $10.62 1 126 763
2019-07-15 $10.95 $10.97 $10.50 $10.60 1 220 342
2019-07-12 $10.97 $11.07 $10.63 $11.05 1 900 304
2019-07-11 $11.26 $11.30 $10.75 $10.91 1 839 464
2019-07-10 $11.11 $11.29 $10.95 $11.24 3 012 451
2019-07-09 $10.86 $11.20 $10.77 $11.13 2 116 247
2019-07-08 $11.33 $11.49 $10.70 $10.95 3 183 976
2019-07-05 $11.89 $12.22 $11.26 $11.27 3 136 315
2019-07-03 $11.57 $11.98 $11.35 $11.89 2 731 435
2019-07-02 $11.20 $11.46 $11.18 $11.44 3 042 684
2019-07-01 $11.16 $11.35 $10.70 $11.19 3 381 676
Click to get the best stock tips daily for free!

About ArQule

ArQule ArQule, Inc., a biopharmaceutical company, researches and develops therapeutics for the treatment of cancer and rare diseases in the United States. Its lead product candidate is tivantinib (ARQ 197), a small molecule inhibitor of the c-Met receptor tyrosine kinase and its biological pathway, which is in Phase III clinical trial for the treatment of liver cancer and non-small cell lung cancer; Phase II clinical trial for the treatment of mesotheli... ARQL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT